Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samir H Moussa

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Genes & Development|October 19, 2011
Active Bax and Bak are functional holinsXiaming Pang, Samir H Moussa, Natalie M Targy, et al.
Nature Chemical Biology|December 1, 2015
A synthetic lethal approach for compound and target identification in Staphylococcus aureusLincoln Pasquina, John P Santa Maria, B McKay Wood, et al.
The Lancet. Microbe|February 8, 2026
Microbiological analysis and whole-genome sequencing of Neisseria gonorrhoeae from the microbiological failures in the international, zoliflodacin, phase 3, clinical trial for treatment of uncomplicated urogenital gonorrhoea: a retrospective, genomic, observational studyMagnus Unemo, Daniel Golparian, Varalakshmi Elango, et al.
Mbio|March 14, 2019
Targeting Multidrug-Resistant <i>Acinetobacter</i> spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic AgentMelissa D Barnes, Vijay Kumar, Christopher R Bethel, et al.
Bioorganic & Medicinal Chemistry|November 7, 2020
N-Hydroxyformamide LpxC inhibitors, their in vivo efficacy in a mouse Escherichia coli infection model, and their safety in a rat hemodynamic assayTakeru Furuya, Adam B Shapiro, Janelle Comita-Prevoir, et al.
Nature Microbiology|July 1, 2017
ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumanniiThomas F Durand-Réville, Satenig Guler, Janelle Comita-Prevoir, et al.
Nature|September 16, 2021
Rational design of a new antibiotic class for drug-resistant infectionsThomas F Durand-Reville, Alita A Miller, John P O'Donnell, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Genes & Development|October 19, 2011
Active Bax and Bak are functional holinsXiaming Pang, Samir H Moussa, Natalie M Targy, et al.
Nature Chemical Biology|December 1, 2015
A synthetic lethal approach for compound and target identification in Staphylococcus aureusLincoln Pasquina, John P Santa Maria, B McKay Wood, et al.
The Lancet. Microbe|February 8, 2026
Microbiological analysis and whole-genome sequencing of Neisseria gonorrhoeae from the microbiological failures in the international, zoliflodacin, phase 3, clinical trial for treatment of uncomplicated urogenital gonorrhoea: a retrospective, genomic, observational studyMagnus Unemo, Daniel Golparian, Varalakshmi Elango, et al.
Mbio|March 14, 2019
Targeting Multidrug-Resistant <i>Acinetobacter</i> spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic AgentMelissa D Barnes, Vijay Kumar, Christopher R Bethel, et al.
Bioorganic & Medicinal Chemistry|November 7, 2020
N-Hydroxyformamide LpxC inhibitors, their in vivo efficacy in a mouse Escherichia coli infection model, and their safety in a rat hemodynamic assayTakeru Furuya, Adam B Shapiro, Janelle Comita-Prevoir, et al.
Nature Microbiology|July 1, 2017
ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumanniiThomas F Durand-Réville, Satenig Guler, Janelle Comita-Prevoir, et al.
Nature|September 16, 2021
Rational design of a new antibiotic class for drug-resistant infectionsThomas F Durand-Reville, Alita A Miller, John P O'Donnell, et al.
Pageof 3